Nzx Magazine New Zealand Issue 046 -

Published: May 2, 2026 Reading Time: 7 minutes

FPH is pivoting hard into home-based respiratory care . Gradon notes that 60% of their R&D budget is now devoted to miniaturization for home use, a direct result of the "hospital-at-home" trend that survived COVID. Deep Dive: The Carbon Credit Conundrum Page 42 of Issue 046 features a sobering analysis of the New Zealand Emissions Trading Scheme (NZ ETS) by Dr. Rangi Mātātā , an environmental economist.

arrives at a critical inflection point. Released in the first half of 2026, this edition captures a market recovering from the turbulence of the post-COVID normalization period and the high-inflation hangover of 2023–2025. With the OCR (Official Cash Rate) holding steady at 4.25% and global trade routes reconfiguring, editors have framed Issue 046 around three pillars: Resilience , Green Transition , and Passive Alpha . NZX Magazine New Zealand Issue 046

The article posits that while carbon credits (NZUs) were once the darlings of alternative investment, a government review in late 2025 has flooded the market with allowances, crashing the spot price to $48 per unit (down from a peak of $89).

If you have capital gains from a stock like FPH or IFT, you can realize losses from laggards like SKT or SML to offset your tax liability. Published: May 2, 2026 Reading Time: 7 minutes

While the dairy sector remains volatile (Fonterra’s latest farmgate milk price forecast sits at $8.50/kg MS), the magazine points to surprising resilience in and aquaculture . “Investors have been hiding in utilities and property for two years,” Wills writes. “Issue 046 argues that the rotation has begun. Look at cyclicals, but be selective.” A centerpiece chart tracks the divergence between listed infrastructure (down 2% YTD) and discretionary retail (up 11% YTD), suggesting that the Kiwi consumer is cautiously opening their wallet again. Feature Interview: The CEO of Fisher & Paykel Healthcare One of the most anticipated segments of any NZX Magazine issue is the one-on-one CEO interview. For Issue 046 , the editors secured an exclusive sit-down with Lewis Gradon of Fisher & Paykel Healthcare (FPH).

This issue is essential reading for any Kiwi with skin in the game. It is less doom-laden than Issue 045 (which focused on the construction slowdown) and more pragmatic than Issue 044 (the crypto hype edition). The strength of lies in its sector rotation thesis—convincing investors to move cash from term deposits (rates are dropping) back into equities, specifically tech and select property. Rangi Mātātā , an environmental economist

In a candid conversation, Gradon addresses the post-pandemic hangover in hospital capital equipment spending. He reveals that the company’s new $400 million high-tech manufacturing facility in Tijuana, Mexico (dubbed "Campus Cosy"), is now fully operational, derisking supply chains away from a pure China-Taiwan strait dependency.